$33.0M
The Cambridge wound care company raised the Series C financing from existing backers to fund US market expansion and product reimbursement.
Inotec develops wearable continuous topical oxygen therapy devices for chronic wound care.
Cambridge-based medical technology company developing continuous topical oxygen therapy devices to treat hard-to-heal chronic wounds.
Mel Vinton
Inventor
Craig Kennedy
CEO
The Cambridge wound care company raised the Series C financing from existing backers to fund US market expansion and product reimbursement.